TC_logo

Treating DED starts with MGD​

Learn more about the only heat and expression device designed to evacuate obstructed meibomian glands in treating MGD while harnessing a natural blink experience.

Request a call from a Rep.

The TearCare® System

The TearCare® System is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands.

TEARCARE SmartLids®

  • Optimal targeted heat
  • 41° to 45°C for up to 15 minutes
  • Openeye design for natural blinking
  • Universal fit

Clearance Assistant

  • Meibomian gland expression
  • Real-time visualization
  • Precise gland targeting

TEARCARE SmartHub

  • Highly Portable
  • Brainpower behind consistent heat
  • Monitors temperature 240x per second

Indications for Use: The TearCare® System is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands. 
The TearCare® System may not be right for everyone. Please see Instructions for Use or visit TearCare.com for Contraindications, Warnings, Precautions and Adverse Events.

SightSciences_Logo_White_2410x880

© 2022 Sight Sciences, Inc.     8/22     TC-2544-US.v1     TearCare® is a registered trademark of Sight Sciences.